Last reviewed · How we verify
NCT07264114
Aquatic High-Intensity Interval Training for Parkinson's Disease
NA trial testing Aquatic HIIT with adherence/support package in Parkinson Disease in 56 participants. Participants enrolled and being followed up; not accepting new ones.
10 March 2026
Quick facts
| Lead sponsor | Pardis Specialized Wellness Institute |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 56 |
| Start date | 10 December 2025 |
| Primary completion | 10 March 2026 |
| Estimated completion | 10 June 2026 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- Aquatic HIIT with adherence/support package
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
Pardis Specialized Wellness Institute
Who can join
Adults 55 to 75, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized, single-center, parallel-group superiority trial will evaluate the effect of an 8-week aquatic High-Intensity Interval Training (HIIT) program on balance, physical function, and sarcopenia-related outcomes in individuals with Parkinson's disease (PD). The intervention aims to deliver Tabata-style aquatic HIIT (3 sessions/week) in a therapeutic pool to determine adherence and preliminary efficacy compared with standard care (no structured exercise program).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07264114
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Pardis Specialized Wellness Institute trials
Trials by the same sponsor.
- NCT07525973 — The Effect of Eye Exercises on Motor Performance, Balance, and Fall Risk in Parkinson's Disease · NA · not yet recruiting
- NCT07000006 — The Effect of Exercise on Low Back Pain in Peritoneal Dialysis Patients · NA · completed
- NCT06958380 — Corrective Exercise and Rehabilitation in Fanconi Anemia: A Case Study · NA · completed
- NCT06877962 — The Effect of Home-based Exercise on Postural Abnormalities · NA · completed
- NCT06787599 — The Effect of Home Based Tele-Exercise on Peritoneal Dialysis Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07264114 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pardis Specialized Wellness Institute
- Last refreshed: 18 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07264114.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing